Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
This bill (Joe Fiandra Access to Home Infusion Act of 2025) amends Medicare (Title XVIII, Social Security Act §1861(n)) to allow coverage of external infusion pumps and associated home infusion drugs or supplies that otherwise would not meet the regulatory "appropriate for use in the home" requirement, provided specified criteria are met. Those criteria include (1) the FDA-approved prescribing information requires administration by or under supervision of a health care professional, (2) a "qualified home infusion therapy supplier" administers or supervises administration in the patient’s home, and (3) the drug is infused at least 12 times per year or requires an external infusion pump per CMS determination.
Fiscal impact: centrists and conservatives worry about increased Medicare spending and demand offsets; liberals emphasize access and patient benefits and are more willing to accept costs for access (some uncertainty).
Relative to its intended legislative type, this bill is a concise substantive amendment to Medicare coverage law that specifies qualifying conditions and an implementation date but leaves several operational, fiscal, definitional, and oversight elements unaddressed in the provided text.
This bill (Joe Fiandra Access to Home Infusion Act of 2025) amends Medicare (Title XVIII, Social Security Act §1861(n)) to allow coverage of external infusion pumps and associated home infusion drugs or supplies that otherwise would not meet the regulatory "appropriate for use in the home" requirement, provided specified criteria are met.
Those criteria include (1) the FDA-approved prescribing information requires administration by or under supervision of a health care professional, (2) a "qualified home infusion therapy supplier" administers or supervises administration in the patient’s home, and (3) the drug is infused at least 12 times per year or requires an external infusion pump per CMS determination.
The provision takes effect beginning the first calendar quarter one year after enactment.
On content alone, the bill is targeted, technocratic, and devoid of polarizing ideological language, which favors consideration and potential bipartisan support. However, it likely increases Medicare spending (or redistributes where spending occurs), will draw active stakeholder lobbying (both supporters and opponents), lacks detailed implementation language in the provided text, and would need committee approval and a favorable budgetary score. Those factors lower the standalone likelihood absent accommodation in a larger negotiation vehicle.
Relative to its intended legislative type, this bill is a concise substantive amendment to Medicare coverage law that specifies qualifying conditions and an implementation date but leaves several operational, fiscal, definitional, and oversight elements unaddressed in the provided text.
Fiscal impact: centrists and conservatives worry about increased Medicare spending and demand offsets; liberals emphasize access and patient benefits and are more willing to accept costs for access (some uncertainty).
These are examples from the analysis, not a ranked list of the most-affected groups.
Fiscal impact: centrists and conservatives worry about increased Medicare spending and demand offsets; liberals emphasize access and patient benefits and are more willing to accept costs for access (some uncertainty).
A mainstream liberal would likely view this bill positively as an expansion of Medicare access that enables more patients to receive clinically necessary infusion therapies at home, increasing patient choice and convenience.
They would see it as reducing unnecessary institutional care and supporting chronically ill and disabled people who need frequent infusions.
They would nevertheless watch implementation details and safeguards—such as supplier qualifications, worker protections, and protections against increased out-of-pocket costs—to ensure equity and quality.
A centrist/moderate would likely be generally favorable toward this targeted expansion because it is narrowly written, time-delimited (effective one year after enactment), and focused on clinical criteria.
They would view the bill as a pragmatic way to allow medically necessary therapies at home, potentially improving efficiency and patient satisfaction.
At the same time, they would be cautious about possible increases in Medicare spending and emphasize the need for clear supplier standards, payment calibration, and anti-fraud measures.
A mainstream conservative would be skeptical of this bill as an expansion of Medicare coverage that broadens federal spending and federal involvement in what could be state-managed or private arrangements.
They would be concerned that the change could increase program costs and invite fraud or waste without clear offsets.
Some conservatives might accept the bill if it demonstrably reduces more expensive institutional care and contains strong guardrails, but absent explicit budgetary offsets and tight implementation controls they would tend to oppose or be cautious about it.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is targeted, technocratic, and devoid of polarizing ideological language, which favors consideration and potential bipartisan support. However, it likely increases Medicare spending (or redistributes where spending occurs), will draw active stakeholder lobbying (both supporters and opponents), lacks detailed implementation language in the provided text, and would need committee approval and a favorable budgetary score. Those factors lower the standalone likelihood absent accommodation in a larger negotiation vehicle.
The bill has not accumulated any surfaced votes yet.
Fiscal impact: centrists and conservatives worry about increased Medicare spending and demand offsets; liberals emphasize access and patien…
On content alone, the bill is targeted, technocratic, and devoid of polarizing ideological language, which favors consideration and potenti…
Relative to its intended legislative type, this bill is a concise substantive amendment to Medicare coverage law that specifies qualifying conditions and an implementation date but leaves several operational, fiscal, de…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.